跳至主要内容
临床试验/RBR-23snwx
RBR-23snwx招募中未知

Clinical trial about the efficacy, safety and mechanisms of action of Microneedling and oral Tranexamic Acid in the treatment of facial Melasma

Escola Paulista de Medicina (EPM/UNIFESP)0 个研究点开始时间: 2018年6月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 —(—)
性别
Female

入选标准

  • women with mild to severe facial melasma with moderately to severe mMASI clinically proven by a dermatologist titled during the medical visit and who have been untreated for melasma for at least 30 days, except for the use of sunscreen

排除标准

  • other concomitant facial dermatoses, photosensitivity dermatoses, collagenoses, blood dyscrasias or under the use of anticoagulant medication, immunosuppressed; pregnant and lactating women;phenotypic extremes red and black, because melasma is rarely mentioned in these groups. Obese, users of oral contraceptives, sedentary or with a personal or family history of previous thrombotic event have a higher risk of thromboembolism, so will be deallocated from the block with oral tranexamic acid

研究者

发起方
Escola Paulista de Medicina (EPM/UNIFESP)

相似试验